1. Home
  2. JXG vs VANI Comparison

JXG vs VANI Comparison

Compare JXG & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

HOLD

Current Price

$6.65

Market Cap

103.6M

Sector

N/A

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.19

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JXG
VANI
Founded
N/A
1998
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.6M
119.0M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
JXG
VANI
Price
$6.65
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
23.1K
203.0K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.92
52 Week High
$12.00
$1.92

Technical Indicators

Market Signals
Indicator
JXG
VANI
Relative Strength Index (RSI) 30.44 34.97
Support Level $6.19 $1.13
Resistance Level $10.09 $1.25
Average True Range (ATR) 0.87 0.07
MACD -0.23 -0.02
Stochastic Oscillator 2.76 0.00

Price Performance

Historical Comparison
JXG
VANI

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products. The Company's operations are located in the PRC and all of the Company's revenue is derived from sales to customers in the PRC region.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

Share on Social Networks: